Quebec pharmaceutical company Mantra Pharma recently launched the first-ever generic CLAVULIN antibiotic, providing a significant supply of the drug amid a Canadian pediatric drug shortage. The composite product of amoxicillin and clavulanic acid is commonly used to treat bronchitis, pneumonia and ear infections in children. No equivalent alternative to the reference drug has been available until now. Source